BRCA1/2 reversion mutations as a mechanism of acquired drug resistance in BRCA1/2-mutated cancers

被引：0
|
作者：
Taniguchi, Toshiyasu [1 ]
机构：
[1] Tokai Univ, Dept Mol Life Sci, Sch Med, Tokyo, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S11-5
引用
收藏
页码：260 / 260
页数：1
相关论文
共 50 条
  • [1] Secondary BRCA1/2 mutations are associated with platinum resistance in BRCA1/2-mutated ovarian carcinomas
    Norguist, B.
    Taniguchi, T.
    Wurz, K.
    Karlan, B.
    Villegas, E.
    Sakai, W.
    Swisher, E.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 594 - 594
  • [2] GENOMICS OF BRCA1/2-MUTATED BREAST CANCERS
    Jonkers, J.
    [J]. CELLULAR ONCOLOGY, 2010, 32 (03): : 162 - 162
  • [3] Secondary BRCA1/2 mutations are associated with platinum resistance in a large series of BRCA1/2-mutated ovarian carcinomas
    Norquist, B.
    Sakai, W.
    Wurz, K.
    Karlan, B.
    Taniguchi, T.
    Swisher, E.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S4 - S4
  • [4] Secondary mutations of BRCA1/2 and drug resistance
    Dhillon, Kiranjit K.
    Swisher, Elizabeth M.
    Taniguchi, Toshiyasu
    [J]. CANCER SCIENCE, 2011, 102 (04): : 663 - 669
  • [5] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [6] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    [J]. MODERN PATHOLOGY, 2019, 32
  • [7] Responses to carboplatin in BRCA1/2-mutated breast cancer
    Burki, Talha Khan
    [J]. LANCET ONCOLOGY, 2018, 19 (07): : E337 - E337
  • [8] Molecular profiling comparison of BRCA1/2-mutated and BRCA1/2 non-mutated triple-negative breast cancer (TNBC)
    Arguello, D.
    Abbott, B.
    Reddy, S.
    Gatalica, Z.
    Obeid, E.
    Goldstein, L.
    [J]. CANCER RESEARCH, 2016, 76
  • [9] The Role of BRCA1/2-Mutated Tumor Microenvironment in Breast Cancer
    Miklikova, Svetlana
    Trnkova, Lenka
    Plava, Jana
    Bohac, Martin
    Kuniakova, Marcela
    Cihova, Marina
    [J]. CANCERS, 2021, 13 (03) : 1 - 17
  • [10] Mathematical modeling for prediction of secondary BRCA1 and BRCA2 mutations in ovarian cancers with deleterious germline BRCA1 and BRCA2 mutations
    Botesteanu, Dana-Adriana
    Levy, Doron
    Lee, Jung-Min
    [J]. CANCER RESEARCH, 2016, 76
12345